181 related articles for article (PubMed ID: 33444691)
1. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer.
Sun S; Liu Y; He C; Hu W; Liu W; Huang X; Wu J; Xie F; Chen C; Wang J; Lin Y; Zhu W; Yan G; Cai J; Li S
Cancer Lett; 2021 Apr; 502():9-24. PubMed ID: 33444691
[TBL] [Abstract][Full Text] [Related]
2. A systemically deliverable Vaccinia virus with increased capacity for intertumoral and intratumoral spread effectively treats pancreatic cancer.
Marelli G; Chard Dunmall LS; Yuan M; Di Gioia C; Miao J; Cheng Z; Zhang Z; Liu P; Ahmed J; Gangeswaran R; Lemoine N; Wang Y
J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33500259
[TBL] [Abstract][Full Text] [Related]
3. A classical PKA inhibitor increases the oncolytic effect of M1 virus via activation of exchange protein directly activated by cAMP 1.
Li K; Liang J; Lin Y; Zhang H; Xiao X; Tan Y; Cai J; Zhu W; Xing F; Hu J; Yan G
Oncotarget; 2016 Jul; 7(30):48443-48455. PubMed ID: 27374176
[TBL] [Abstract][Full Text] [Related]
4. Suppression of CCDC6 sensitizes tumor to oncolytic virus M1.
Liu Y; Li K; Zhu WB; Zhang H; Huang WT; Liu XC; Lin Y; Cai J; Yan GM; Qiu JG; Peng L; Liang JK; Hu C
Neoplasia; 2021 Jan; 23(1):158-168. PubMed ID: 33338804
[TBL] [Abstract][Full Text] [Related]
5. Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.
Zhang Z; Li W; Procissi D; Tyler P; Omary RA; Larson AC
Nanomedicine (Lond); 2014; 9(8):1181-92. PubMed ID: 24024571
[TBL] [Abstract][Full Text] [Related]
6. Gemcitabine combined with an engineered oncolytic vaccinia virus exhibits a synergistic suppressive effect on the tumor growth of pancreatic cancer.
Chen W; Fan W; Ru G; Huang F; Lu X; Zhang X; Mou X; Wang S
Oncol Rep; 2019 Jan; 41(1):67-76. PubMed ID: 30365143
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of the IRE1α-Autophagy Axis Enhances the Antitumor Effects of the Oncolytic Virus M1.
Li K; Hu C; Xing F; Gao M; Liang J; Xiao X; Cai J; Tan Y; Hu J; Zhu W; Yin W; Li Y; Chen W; Lu B; Mai J; Qiu P; Su X; Yan G; Zhang H; Lin Y
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263275
[TBL] [Abstract][Full Text] [Related]
8. Selective Antagonism of Bcl-xL Potentiates M1 Oncolysis by Enhancing Mitochondrial Apoptosis.
Tan Y; Lin Y; Li K; Xiao X; Liang J; Cai J; Guo L; Li C; Zhu W; Xing F; Mai J; Gu J; Tan X; Yin W; Lu B; Qiu P; Su X; Gao M; Hu J; He S; Lu L; Gong S; Yan G; Zhang H
Hum Gene Ther; 2018 Aug; 29(8):950-961. PubMed ID: 28750564
[TBL] [Abstract][Full Text] [Related]
9. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X
Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855
[TBL] [Abstract][Full Text] [Related]
10. Intravenous injections of the oncolytic virus M1 as a novel therapy for muscle-invasive bladder cancer.
Hu C; Liu Y; Lin Y; Liang JK; Zhong WW; Li K; Huang WT; Wang DJ; Yan GM; Zhu WB; Qiu JG; Gao X
Cell Death Dis; 2018 Feb; 9(3):274. PubMed ID: 29449555
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte-associated protein 4 antibody aggrandizes antitumor immune response of oncolytic virus M1 via targeting regulatory T cells.
Liu W; Liu Y; Hu C; Xu C; Chen J; Chen Y; Cai J; Yan G; Zhu W
Int J Cancer; 2021 Sep; 149(6):1369-1384. PubMed ID: 34086978
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.
Watanabe K; Luo Y; Da T; Guedan S; Ruella M; Scholler J; Keith B; Young RM; Engels B; Sorsa S; Siurala M; Havunen R; Tähtinen S; Hemminki A; June CH
JCI Insight; 2018 Apr; 3(7):. PubMed ID: 29618658
[TBL] [Abstract][Full Text] [Related]
13. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses.
Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C
EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166
[TBL] [Abstract][Full Text] [Related]
14. AduPARE1A and gemcitabine combined treatment trigger synergistic antitumor effects in pancreatic cancer through NF-κB mediated uPAR activation.
Maliandi MV; Mato-Berciano A; Sobrevals L; Roué G; José A; Fillat C
Mol Cancer; 2015 Jul; 14():146. PubMed ID: 26227809
[TBL] [Abstract][Full Text] [Related]
15. Comparison of combination therapies in the management of locally advanced pancreatic cancer: Induction chemotherapy followed by irreversible electroporation vs radiofrequency ablation.
He C; Wang J; Zhang Y; Cai Z; Lin X; Li S
Cancer Med; 2020 Jul; 9(13):4699-4710. PubMed ID: 32410380
[TBL] [Abstract][Full Text] [Related]
16. Irreversible Electroporation Combined with Checkpoint Blockade and TLR7 Stimulation Induces Antitumor Immunity in a Murine Pancreatic Cancer Model.
Narayanan JSS; Ray P; Hayashi T; Whisenant TC; Vicente D; Carson DA; Miller AM; Schoenberger SP; White RR
Cancer Immunol Res; 2019 Oct; 7(10):1714-1726. PubMed ID: 31409607
[TBL] [Abstract][Full Text] [Related]
17. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
18. Oncosuppressive suicide gene virotherapy "PVH1-yCD/5-FC" for pancreatic peritoneal carcinomatosis treatment: NFκB and Akt/PI3K involvement.
Réjiba S; Bigand C; Parmentier C; Masmoudi A; Hajri A
PLoS One; 2013; 8(8):e70594. PubMed ID: 23967078
[TBL] [Abstract][Full Text] [Related]
19. Prognostic factor analysis of irreversible electroporation for locally advanced pancreatic cancer - A multi-institutional clinical study in Asia.
Yang PC; Huang KW; Pua U; Kim MD; Li SP; Li XY; Liang PC
Eur J Surg Oncol; 2020 May; 46(5):811-817. PubMed ID: 31839436
[TBL] [Abstract][Full Text] [Related]
20. Anti-Tumor Effects of MAPK-Dependent Tumor-Selective Oncolytic Vaccinia Virus Armed with CD/UPRT against Pancreatic Ductal Adenocarcinoma in Mice.
Kurosaki H; Nakatake M; Sakamoto T; Kuwano N; Yamane M; Ishii K; Fujiwara Y; Nakamura T
Cells; 2021 Apr; 10(5):. PubMed ID: 33922406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]